cadazolid

J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
Endpoints
Tue, 04/17/18 - 11:08 am
JNJ
Actelion
antibiotics
C. difficile
cadazolid
Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
JNJ
Actelion
clinical trials
M&A
antibiotics
cadazolid
Actelion Drug to Move into Phase III
Yahoo/Zacks
Wed, 12/26/12 - 09:24 pm
Actelion
cadazolid
Clostridium Difficile